chemotherapy
Investigators from Atrium Health recently published a study comparing pretreatment and posttreatment testing, showing a strong benefit in a real-world clinical cohort.
Saladax Gets Canadian Approval for Chemotherapy Monitoring Test
The test is designed to monitor levels of 5-fluorouracil, a widely used chemotherapeutic with a range of potential adverse effects.
The test, called Neutrocheck, relies on a lateral flow assay that can be run on a small, in-house devised device that can fit in the palm of a user.
Novacyt Secures IVDR Certification for Genetic Chemotoxicity Test
The assay is designed to identify cancer patients with an enzyme deficiency that can cause dangerous side effects from 5-fluorouracil treatment.
FDA Updates Xeloda Labeling to Make DPYD Variant Risks More Explicit
In response to a citizen petition, the FDA has added more specific language about testing patients for DPYD gene variants that place them at risk for severe treatment-related toxicities.